litlas
ログインアカウント作成

George W. Sledge

1986–2026 年に発表

別表記
George W Sledge
160
論文数
38,640
被引用数
92
h 指数
151
i10 指数

被引用数

George W. Sledge の年別被引用数1971 年: 被引用 1 件1980 年: 被引用 1 件1981 年: 被引用 1 件1987 年: 被引用 2 件1988 年: 被引用 4 件1989 年: 被引用 5 件1990 年: 被引用 4 件1991 年: 被引用 3 件1992 年: 被引用 10 件1993 年: 被引用 5 件1994 年: 被引用 4 件1995 年: 被引用 7 件1996 年: 被引用 8 件1997 年: 被引用 15 件1998 年: 被引用 15 件1999 年: 被引用 42 件2000 年: 被引用 42 件2001 年: 被引用 49 件2002 年: 被引用 103 件2003 年: 被引用 116 件2004 年: 被引用 120 件2005 年: 被引用 142 件2006 年: 被引用 140 件2007 年: 被引用 140 件2008 年: 被引用 157 件2009 年: 被引用 221 件2010 年: 被引用 254 件2011 年: 被引用 245 件2012 年: 被引用 257 件2013 年: 被引用 265 件2014 年: 被引用 210 件2015 年: 被引用 296 件2016 年: 被引用 342 件2017 年: 被引用 349 件2018 年: 被引用 384 件2019 年: 被引用 1,277 件2020 年: 被引用 1,553 件2021 年: 被引用 1,452 件2022 年: 被引用 1,109 件2023 年: 被引用 821 件2024 年: 被引用 1,181 件2025 年: 被引用 556 件2026 年: 被引用 30 件1972〜1979 年は被引用が無いため表示していません1982〜1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,569 件、この内訳の 26.8%中国: 引用元論文 1,420 件、この内訳の 8.3%イタリア: 引用元論文 1,002 件、この内訳の 5.9%イギリス: 引用元論文 907 件、この内訳の 5.3%ドイツ: 引用元論文 792 件、この内訳の 4.7%フランス: 引用元論文 664 件、この内訳の 3.9%カナダ: 引用元論文 657 件、この内訳の 3.9%スペイン: 引用元論文 611 件、この内訳の 3.6%オーストラリア: 引用元論文 450 件、この内訳の 2.6%日本: 引用元論文 450 件、この内訳の 2.6%スイス: 引用元論文 431 件、この内訳の 2.5%ベルギー: 引用元論文 423 件、この内訳の 2.5%
0%26.8%その他 27.4%

機関

分野

  • Medicine52%
  • Biochemistry, Genetics and Molecular Biology38.9%
  • Immunology and Microbiology2.4%
  • Computer Science1.6%
  • Engineering1%
  • Materials Science0.8%
  • その他3.3%

トピック

  • Breast Cancer Treatment Studies7.8%
  • HER2/EGFR in Cancer Research5.6%
  • Advanced Breast Cancer Therapies5.6%
  • Cancer Genomics and Diagnostics4.6%
  • Cancer Treatment and Pharmacology3.5%
  • Cancer Immunotherapy and Biomarkers2.6%
  • その他70.3%

共著者

全論文

検索で開く
  1. Liquid biopsy enters the clinic — implementation issues and future challenges

    著者: Michail Ignatiadis, George W. Sledge, Stefanie S. Jeffrey - Nature Reviews Clinical Oncology 2021 被引用: 1,160

  2. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

    著者: Joseph A. Sparano, Robert J. Gray, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Peter M. Ravdin, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, Jeffrey L. Berenberg, Jeffrey S. Abrams, George W. Sledge - New England Journal of Medicine 2018 被引用: 2,369

  3. MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

    著者: George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han Koh, Eva‐Maria Grischke, Martin Frenzel, Yong Lin, Susana Barriga, Ian C. P. Smith, Nawel Bourayou, Antonio Llombart‐Cussac - Journal of Clinical Oncology 2017 被引用: 1,656

  4. 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    著者: Fátima Cardoso, A. Costa, Elżbieta Senkus, Matti Aapro, Fabrice André, Carlos H. Barrios, Jonas Bergh, G.S. Bhattacharyya, Laura Biganzoli, Maria João Cardoso, L. Carey, D. Corneliussen-James, Giuseppe Curigliano, Véronique Dièras, N. El Saghir, Alexandru Eniu, Lesley Fallowfield, D. Fenech, Prudence A. Francis, Karen A. Gelmon, Alessandra Gennari, Nadia Harbeck, Clifford A. Hudis, Bella Kaufman, Ian E. Krop, Musa Mayer, Hanneke Meijer, Shirley Mertz, Shinji Ohno, Olivia Pagani, Efthymios Papadopoulos, Fedro A. Peccatori, Frédérique Penault‐Llorca, Martine Piccart, Jean‐Yves Pierga, Hope S. Rugo, Lillie D. Shockney, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Andrew Tutt, Daniel Vorobiof, Binghe Xu, Larry Norton, Eric P. Winer - Annals of Oncology 2016 被引用: 2,062

  5. The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2

    著者: George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han Koh, Eva‐Maria Grischke, PierFranco Conte, Yi Lu, Susana Barriga, Karla Hurt, Martin Frenzel, Stephen Johnston, Antonio Llombart‐Cussac - JAMA Oncology 2019 被引用: 987

  6. Integrated digital error suppression for improved detection of circulating tumor DNA

    著者: Aaron M. Newman, Alexander F. Lovejoy, Daniel M. Klass, David M. Kurtz, Jacob J. Chabon, Florian Scherer, Henning Stehr, Chih Long Liu, Scott V. Bratman, Carmen Say, Li Zhou, Justin N. Carter, Robert B. West, George W. Sledge, Joseph B. Shrager, Billy W. Loo, Joel W. Neal, Heather A. Wakelee, Maximilian Diehn, Ash A. Alizadeh - Nature Biotechnology 2016 被引用: 1,144

  7. Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

    著者: Sylvia Adams, Robert J. Gray, Sandra Demaria, Lori J. Goldstein, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Molin Wang, Vicky Jones, Thomas J. Saphner, Antonio C. Wolff, William C. Wood, Nancy E. Davidson, George W. Sledge, Joseph A. Sparano, Sunil Badve - Journal of Clinical Oncology 2014 被引用: 1,333

  8. Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

    著者: Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, Jeffrey L. Berenberg, Jeffrey S. Abrams, George W. Sledge - New England Journal of Medicine 2019 被引用: 555

  9. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

    著者: Joseph A. Sparano, Robert J. Gray, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Edith A. Perez, John A. Olson, JoAnne Zujewski, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Peter M. Ravdin, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, James N. Atkins, Jeffrey L. Berenberg, George W. Sledge - New England Journal of Medicine 2015 被引用: 1,439

  10. 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

    著者: Fátima Cardoso, Shani Paluch–Shimon, Eva Schumacher-Wulf, Leonor Vasconcelos de Matos, Karen A. Gelmon, Matti Aapro, Jyoti Bajpai, Carlos H. Barrios, Jonas Bergh, Elizabeth Bergsten-Nordström, Laura Biganzoli, Maria João Cardoso, Lisa A. Carey, Mariana Chávez‐MacGregor, Runcie C.W. Chidebe, Javier Cortés, Giuseppe Curigliano, Rebecca Dent, Nagi S. El Saghir, Alexandru Eniu, Lesley Fallowfield, Prudence A. Francis, Sandra X. Franco Millan, Jenny Gilchrist, Joseph Gligorov, William J. Gradishar, Renate Haidinger, Nadia Harbeck, Xichun Hu, Ranjit Kaur, Belinda E. Kiely, Sungbae Kim, Smruti Koppikar, Marion Kuper‐Hommel, Frédéric Lecouvet, Ginny Mason, Shirley Mertz, Volkmar Müller, Claire Myerson, Silvia P. Neciosup, Birgitte Vrou Offersen, Shinji Ohno, Olivia Pagani, Ann H. Partridge, Frédérique Penault‐Llorca, Aleix Prat, Hope S. Rugo, Elżbieta Senkus, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Daniel Vorobiof, Peter Vuylsteke, Theresa Wiseman, Binghe Xu, Alberto Costa, Larry Norton, Eric P. Winer - The Breast 2024 被引用: 197

  11. Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant

    著者: Sara M. Tolaney, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Eva-Maria Grischke, Antonio Llombart-Cussac, Hatem Soliman, Hong Wang, Sameera Wijayawardana, Valerie M. Jansen, Lacey M. Litchfield, George W. Sledge - Clinical Cancer Research 2022 被引用: 105

  12. Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

    著者: Edith A. Perez, Edward H. Romond, Vera J. Suman, Jong‐Hyeon Jeong, George W. Sledge, Charles E. Geyer, Silvana Martino, Priya Rastogi, Julie R. Gralow, Sandra M. Swain, Eric P. Winer, Gerardo Colón‐Otero, Nancy E. Davidson, E. Mamounas, Jo Anne Zujewski, Norman Wolmark - Journal of Clinical Oncology 2014 被引用: 998

  13. Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

    著者: Joseph A. Sparano, Molin Wang, Silvana Martino, Vicky Jones, Edith A. Perez, Tom Saphner, Antonio C. Wolff, George W. Sledge, William C. Wood, Nancy E. Davidson - New England Journal of Medicine 2008 被引用: 1,029

  14. Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer

    著者: Joseph A. Sparano, Anne O’Neill, Katherine Alpaugh, Antonio C. Wolff, Donald W. Northfelt, Chau T. Dang, George W. Sledge, Kathy D. Miller - JAMA Oncology 2018 被引用: 199

  15. Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review

    著者: Jennifer L. Caswell‐Jin, Sylvia K. Plevritis, Lü Tian, Christopher J. Cadham, Cong Xu, Natasha K. Stout, George W. Sledge, Jeanne S. Mandelblatt, Allison W. Kurian - JNCI Cancer Spectrum 2018 被引用: 328

  16. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

    著者: Kathy S. Albain, William E. Barlow, Steven Shak, Gabriel N. Hortobágyi, Robert B. Livingston, I‐Tien Yeh, Peter M. Ravdin, Roberto Bugarini, Frederick L. Baehner, Nancy E. Davidson, George W. Sledge, Eric P. Winer, Clifford A. Hudis, James N. Ingle, Edith A. Perez, Kathleen I. Pritchard, Lois E. Shepherd, Julie R. Gralow, Carl Yoshizawa, D. Craig Allred, C. Kent Osborne, Daniel F. Hayes - The Lancet Oncology 2009 被引用: 1,405

  17. Wnt signaling in triple negative breast cancer is associated with metastasis

    著者: Nandini Dey, Benjamin G. Barwick, Carlos S. Moreno, Maja Ordanic-Kodani, Zhengjia Chen, Gabriella Oprea‐Ilies, Weining Tang, Charles Catzavelos, Kimberly F. Kerstann, George W. Sledge, Mark Abramovitz, Mark Bouzyk, Pradip De, Brian Leyland‐Jones - BMC Cancer 2013 被引用: 251

  18. Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer

    著者: Joseph A. Sparano, Fengmin Zhao, Silvana Martino, Jennifer A. Ligibel, Edith A. Perez, Tom Saphner, Antonio C. Wolff, George W. Sledge, William C. Wood, Nancy E. Davidson - Journal of Clinical Oncology 2015 被引用: 223

  19. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale

    著者: David T. Eton, David Cella, Kathleen J. Yost, Susan E. Yount, Amy H. Peterman, Donna Neuberg, George W. Sledge, William C. Wood - Journal of Clinical Epidemiology 2004 被引用: 391

  20. Past, Present, and Future Challenges in Breast Cancer Treatment

    著者: George W. Sledge, Eleftherios P. Mamounas, Gabriel N. Hortobágyi, Harold J. Burstein, Pamela J. Goodwin, Antonio C. Wolff - Journal of Clinical Oncology 2014 被引用: 275

  21. Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (E2108)

    著者: Seema A. Khan, Fengmin Zhao, Lori J. Goldstein, David Cella, Mark Basik, Mehra Golshan, Thomas B. Julian, Barbara A. Pockaj, Christine A. Lee, Wajeeha Razaq, Joseph A. Sparano, Gildy V. Babiera, Irene A. Dy, Sarika Jain, Paula Silverman, Carla S. Fisher, Amye J. Tevaarwerk, Lynne I. Wagner, George W. Sledge - Journal of Clinical Oncology 2022 被引用: 178

  22. Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

    著者: Kathy S. Albain, Robert J. Gray, Della Makower, Amir Faghih, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, William C. Wood, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, Jeffrey L. Berenberg, Jeffrey S. Abrams, George W. Sledge, Joseph A. Sparano - JNCI Journal of the National Cancer Institute 2020 被引用: 114

  23. Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

    著者: Lynne I. Wagner, Robert J. Gray, Joseph A. Sparano, Timothy J. Whelan, Sofia F. Garcia, Betina R. Yanez, Amyé Tevaarwerk, Ruth C. Carlos, Kathy S. Albain, John A. Olson, Matthew P. Goetz, Kathleen I. Pritchard, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Worta J. McCaskill-Stevens, Lori M. Minasian, George W. Sledge, David Cella - Journal of Clinical Oncology 2020 被引用: 101

  24. Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer

    著者: Julia D. Ransohoff, Victor Ritter, Natasha Purington, Karen Andrade, Summer S. Han, Mina Liu, Su‐Ying Liang, Esther M. John, Scarlett Lin Gomez, Melinda L. Telli, Lidia Schapira, Haruka Itakura, George W. Sledge, Ami S. Bhatt, Allison W. Kurian - Nature Communications 2023 被引用: 36